Europe's Hidden Gem
We believe that synthetic biology, microbiome research, and the intersection between them can help us tackle critical challenges and make our world healthier, more prosperous and sustainable. We are also convinced that Europe’s strength in fundamental sciences is dramatically under exploited.
- What better way to harness the strengths of Europe’s knowledge economy than investing in its brightest minds? Supporting scientists’ commercialization efforts also means creating new jobs, companies, and even novel industries along with the disruptive technology they bring to market.
- From new cell therapies, to using our own body-dwelling microbes as medicine, to life-saving gene therapies — when it comes to applications in healthcare, the sky is the limit. Europe’s researchers are finding new health applications for Synthetic biology and microbiome work at unprecedented speed.
- Keeping in mind that planet health is human health, there’s nothing more precious than the place we all call home. Mobilizing microbiota and synthetic biology for the environment could help us create better biofuels, restore and conserve the diversity of species, and fight pollution.
Our Focus
The projects and companies we support harness the potential of synthetic biology, microbiome research, and the intersection between them.
The opportunity
Synthetic biology is a multidisciplinary field that uses engineering techniques to modify and improve biological components like living cells. Europe excels in synthetic biology research, however, more funding and support on entrepreneurship are needed to boost opportunities for commercialisation. We’re here to fill the gap.
Our vision
We see a world where synthetic biology plays a transformative role in solving some of the world’s most pressing challenges. We believe that synthetic biology has the potential to revolutionize industries, create new markets, and provide solutions to complex problems that were previously thought to be unsolvable.
Our mission
Our investment company is committed to supporting the development and growth of synthetic biology companies in Europe, the UK, and Israel. Our mission is to identify and invest in companies that are developing cutting-edge synthetic biology technologies, with a focus on those that have the potential to transform industries such as healthcare, agriculture, energy, and environmental sustainability. Our portfolio of investments reflects our commitment to advancing the field of synthetic biology and creating a more sustainable and equitable world.
